An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives

Trial Profile

An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Naloxone (Primary) ; Oxycodone (Primary) ; Laxatives
  • Indications Constipation; Pain
  • Focus Therapeutic Use
  • Acronyms OXN9513GAIN
  • Sponsors Mundipharma International
  • Most Recent Events

    • 01 Dec 2016 Primary endpoint has been met. (Quality of Life)
    • 01 Dec 2016 Results related to quality of life, resource use and costs were published in the Pain and Therapy.
    • 06 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top